Sharemaestro Newsreel

PLSE|Pulse Biosciences Inc|Price:34.270|Chg%:-1.200

TradingKey provides a comprehensive stock analysis for Pulse Biosciences Inc (PLSE), highlighting its strong fundamentals, high growth potential, and "Buy" analyst rating. The company's CellFX Nanosecond Pulsed-Field Ablation (nsPFA) technology is noted as a key innovation, with high institutional ownership and healthy financial indicators …

Align Technology Plans to Add Board Members After Talks With Elliott

Align Technology (ALGN) is reportedly planning to add new independent board members following discussions with activist investor Elliott Investment Management. While the number of new directors and specific individuals were not disclosed, reports indicate that Align is considering a range of candidates, including those …

DENTSPLY SIRONA (XRAY) Expected to Release Earnings on Thursday

DENTSPLY SIRONA (NASDAQ:XRAY) is scheduled to release its Q2 2026 earnings after market close on Thursday, August 6th. Analysts are anticipating earnings of $0.36 per share and revenue of $889.2140 million. The company previously reported Q1 2026 EPS of $0.27, missing estimates, but exceeding …

Anteris Technologies Global(AVR.US) 10% Shareholder Sells US$3.6 Million in Common Stock

A 10% shareholder of Anteris Technologies Global (AVR.US) recently sold US$3.6 million worth of common stock. This significant sale by a major insider could be noteworthy for investors monitoring insider activity.

DENTSPLY SIRONA Inc (XRAY) Q1 2026 Earnings Report - Results, Call & Slides

DENTSPLY SIRONA (XRAY) reported its Q1 2026 earnings, missing EPS estimates at $4.71 against a consensus of $4.85, but beating revenue expectations with $15.36 billion. The company maintained its full-year 2026 guidance, citing improved operating cash flow, debt reduction, early cost savings from restructuring, …

Dentsply Sirona Is Maintained at Neutral by Piper Sandler

Piper Sandler has reiterated its "Neutral" rating for Dentsply Sirona. This indicates the firm's ongoing assessment that the stock is expected to perform in line with the market.

Sanara MedTech to Be Acquired by MiMedx in $35-Per-Share Cash-and-Stock Merger

Sanara MedTech is set to be acquired by MiMedx in a cash-and-stock merger, valuing Sanara at approximately $35 per share. The deal aims to combine two wound-care businesses and is supported by a concurrent voting agreement from holders of about 38.9% of Sanara's voting …

Avantor Q2 Earnings Beat Estimates on VWR Growth, Guidance Raised

Avantor, Inc. AVTR reported second-quarter 2026 adjusted earnings per share (EPS) of 21 cents, down 12.5% from the year-ago quarter. However, the bottom line surpassed the Zacks Consensus Estimate by 10.5%. GAAP EPS for the quarter was 6 cents, down from 9 cents per …

Merit Medical Systems (NASDAQ:MMSI) Updates FY 2026 Earnings Guidance

Merit Medical (MMSI) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates

Merit Medical Systems (NASDAQ:MMSI) Reports Bullish Q2 CY2026, Stock Soars

Femasys Inc. (FEMY) Q1 2026 Earnings: EPS Beat on Narrower Loss, Stock Slips - Analyst Earnings Estimate

Baxter International (BAX) Earnings Date and Reports 2026 $BAX

BAXTER INTERNATIONAL INC Quarterly Earnings Report

BioLife Solutions (BLFS) to Post Earnings on Thursday

Align Technology (ALGN) Reports Record Q2 Revenue, Is The Stock Still Below Fair Value?

ALGN Stock Up Post Q2 Earnings and Revenue Beat, Margins Rise

Pulse Biosciences (PLSE) Expected to Release Earnings on Thursday

AptarGroup (NYSE:ATR) Updates Q3 2026 Earnings Guidance

MiMedx Group (SMTI) details Sanara MedTech buyout and 2027 profit goals

Pulse Biosciences’ Aug. 11 Boston fireside chat will be webcast

Bausch + Lomb (BLCO) Stock Rallies On Margin Gains As Losses Narrow

Avantor (AVTR) Stock Slips As Turnaround Progress Meets Profit Drop

Stevanato Group Announces Marketing Authorizations for Liraglutide-Based Combination Products Incorporating Alina Pen Injector in Multiple European Countries

Stevanato Group announced that its liraglutide-based combination products, incorporating the proprietary Alina pen injector, have received marketing authorizations in Europe. These authorizations cover both Alina 30 for diabetes and Alina 50 for weight management, supporting the growing demand for injectable therapies like GLP-1 treatments. …

Femasys Inc (FEMY) Financial Health: Profitability & Balance Sheet Analysis

This article analyzes the financial health of Femasys Inc (FEMY), noting its current financial score is 5.08, ranking 197 out of 199 in its industry. The company shows stable financial status and low operating efficiency, with recent quarterly revenue increasing by 24.50% and net …

Avantor Inc (AVTR) Institutional Confidence

Avantor Inc (AVTR) has received a high institutional confidence score of 10.00, placing it at the top of the Healthcare Equipment & Supplies industry. This score reflects a significant institutional shareholding proportion of 104.03%, despite a quarter-over-quarter decrease of 11.03%. Barrow Hanley is the …

STAAR Surgical Co (STAA) Institutional Confidence

STAAR Surgical Co (STAA) has an institutional shareholding score of 10.00, placing it first among 199 companies in the Healthcare Equipment & Supplies industry. Institutional shareholding increased by 10.75% quarter-over-quarter, with Steven Cohen being the largest institutional shareholder despite a decrease in his holdings. …

Form 4 Nexgel Inc For: 29 July By Investing.com

This article reports on a Form 4 filing for Nexgel Inc. related to activity on July 29th. It is a brief financial news item from Investing.com, typical of filings news. The article provides the company name and filing date, without further details in the …

Azenta Inc (AZTA) Financial Health: Profitability & Balance Sheet Analysis

Azenta Inc (AZTA) currently holds a financial score of 8.14, placing it in the top 60 of 384 companies in the Biotechnology & Medical Research industry, indicating robust financial health and high operating efficiency. The company recently reported a quarterly revenue of $144.79 million, …

Teleflex Announces FDA BLA Approval of EZPLAZ™ Freeze Dried Plasma

Teleflex Incorporated has received FDA Biologics License Application (BLA) approval for EZPLAZ™ Freeze Dried Plasma (FDP), marking the first FDA-approved freeze-dried plasma product. This approval addresses critical logistical challenges in providing plasma for bleeding-related conditions, especially in emergency and battlefield settings, enabling easier storage …

LeMaitre Vascular Inc (LMAT) Financial Health: Profitability & Balance Sheet Analysis

LeMaitre Vascular Inc (LMAT) has a robust financial status with a current financial score of 9.04, ranking 11th in the Healthcare Equipment & Supplies industry. The company demonstrated high operating efficiency with a 11.16% year-over-year increase in quarterly revenue to $66.55M and a 42.39% …

Repligen Corp Q2 2026: Revenue $204.1M, EPS $0.09— 10-Q Summary

Repligen Corp (RGEN) reported its second-quarter 2026 results, with revenue increasing by 11.9% year-over-year to $204.1 million. Despite the revenue growth, net income declined to $5 million, and diluted earnings per share fell to $0.09 from $0.26 in the prior-year quarter. The company also …

Nexgel Inc (NXGL) Valuation: PE, PB & Fair Value Analysis

This article provides a valuation analysis of Nexgel Inc (NXGL), noting its current valuation score of 7.43, which ranks 123 out of 155 in the Pharmaceuticals industry. It highlights that the company's current P/E ratio is -1.10, indicating a decrease of 7.40% from its …

Anteris Technologies Global Corp (AVR) Financial Health: Profitability & Balance Sheet Analysis

Anteris Technologies Global Corp (AVR) has a robust financial status with a score of 6.53, ranking 149 out of 199 in its industry. Despite this, its operating efficiency is low, and its latest quarterly revenue and net profit have seen decreases of 11.15% and …

ICU Medical Number of Employees 2026 | Employee Count & Headcount Data

As of March 2026, ICU Medical, Inc. (ICUI) has approximately 12,991 employees worldwide, marking a 0.1% growth since 2023 but a 0.5% decline year-over-year. The company is actively hiring with 174 job postings in 2026, although new postings have cooled. The workforce is concentrated …

Baxter International Number of Employees 2026 | Employee Count & Headcount Data

Baxter International (BAX) had approximately 37,088 employees worldwide as of March 2026, marking a 9.5% decline from 2023. The company is actively hiring with 1,578 job postings in 2026, though new postings have slowed. North America holds the largest share of its workforce, and …